Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Costus Root (Saussurea costus) is rich in sesquiterpene lactones—primarily dehydrocostus lactone (up to 46.8%) and costunolide (9.3%)—that exert potent anti-inflammatory effects by inhibiting NF-κB signaling and proinflammatory cytokines, alongside broad-spectrum antimicrobial activity confirmed against both bacterial and fungal pathogens (PMID 37493699). A comprehensive ethnopharmacological review documented its traditional and evidence-based uses spanning respiratory, digestive, hepatoprotective, and thyroid-modulating applications, with a 2020 clinical study showing significant improvement in thyroid function parameters in hypothyroid patients treated with Saussurea costus (PMID 33026044).
Reported Benefits (Provisional)
Origin & History
Costus Root (Saussurea costus) is a perennial herb native to the moist tropical forests and Himalayan foothills of India, Nepal, China, and Southeast Asia. Its aromatic roots are highly prized in traditional medicine systems for their diverse therapeutic applications.
Research Narrative (Provisional)
A 2020 ethnopharmacological review in the Journal of Ethnopharmacology comprehensively catalogued Costus Root's traditional uses and modern pharmacological validation, including anti-inflammatory, hepatoprotective, and antimicrobial bioactivities (Nadda RK et al., PMID 32730877). A 2020 clinical study published in the Saudi Medical Journal demonstrated that Saussurea costus supplementation significantly improved thyroid hormone levels (TSH, T3, T4) in hypothyroid patients, suggesting clinical relevance beyond traditional use (Mujammami M et al., PMID 33026044). In 2023, Ahmed GS et al. published in Anais da Academia Brasileira de Ciências confirming significant antibacterial and antifungal activity of S. costus root extracts against multiple pathogenic strains using disc diffusion and MIC assays (PMID 37493699). A 2024 metabolomic study in the Journal of Ethnopharmacology elucidated how costus root extract restored disrupted metabolic pathways—including lipid metabolism and amino acid biosynthesis—in a propylthiouracil-induced hypothyroidism rat model, providing mechanistic support for its thyroid-modulating properties (Dawood HM et al., PMID 38253277).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Bioactives: Sesquiterpene lactones (costunolide, dehydrocostus lactone), Essential oils, Alkaloids, Flavonoids, Inulin, Resinous compounds
Reported Mechanism (Provisional)
Costunolide and dehydrocostus lactone, the principal sesquiterpene lactones of Costus Root, inhibit NF-κB and AP-1 transcription factor activation by blocking IκBα phosphorylation and degradation, thereby suppressing downstream expression of proinflammatory cytokines (IL-1β, IL-6, TNF-α) and mediators (iNOS, COX-2) in LPS-stimulated macrophages. These lactones also suppress MAPK cascade phosphorylation (ERK1/2, JNK, p38), attenuating inflammatory signal transduction at multiple nodes. Antimicrobial activity is mediated through disruption of fungal ergosterol biosynthesis and bacterial membrane integrity, with demonstrated biofilm inhibition against Candida species (PMID 37493699). In hypothyroidism models, metabolomic analysis reveals that costus root restores dysregulated sphingolipid metabolism, phenylalanine metabolism, and tryptophan pathways, indicating multi-target endocrine modulation (PMID 38253277).
Clinical Narrative (Provisional)
Current evidence relies primarily on in vitro and animal studies, with limited human clinical trial data available. Preclinical research demonstrates costunolide's ability to induce apoptosis in HL-60 leukemia cells and shows antioxidant activity with 76.19% DPPH radical scavenging. One small human study noted EGFR tyrosine kinase inhibition for potential antitumor effects, but specific quantified outcomes were not provided. More large-scale randomized controlled trials are needed to establish clinical efficacy and safety profiles in humans.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.